01 2Latisse
02 8Lumigan/Ganfort
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 378
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 579
2020 Revenue in Millions : 378
Growth (%) : 53
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 514
2021 Revenue in Millions : 579
Growth (%) : -11
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 432
2022 Revenue in Millions : 514
Growth (%) : -16
Main Therapeutic Indication : Ophthalmology
Currency : USD
2017 Revenue in Millions : 689
2016 Revenue in Millions : 688
Growth (%) : 0.1
Main Therapeutic Indication : Ophthalmology
Currency : USD
2018 Revenue in Millions : 684
2017 Revenue in Millions : 689
Growth (%) : -1%
Main Therapeutic Indication : Ophthalmology
Currency : USD
2016 Revenue in Millions : 688
2015 Revenue in Millions : 544
Growth (%) : 26
Main Therapeutic Indication : Hypotrichosis of Eyelashes
Currency : USD
2017 Revenue in Millions : 65
2016 Revenue in Millions : 86
Growth (%) : -25
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 630
2018 Revenue in Millions : 684
Growth (%) : -8
Main Therapeutic Indication : Hypotrichosis of Eyelashes
Currency : USD
2016 Revenue in Millions : 86
2015 Revenue in Millions : 73
Growth (%) : 18